Results 61 to 70 of about 350,390 (302)
A brief overview of current drug repurposing approaches for COVID-19 management [PDF]
This brief overview is intended to shed light on the current drug repositioning (also called drug repurposing) in the therapeutics of the novel coronavirus disease which emerged in 2019 (COVID-19).
Rodrigues, Pedro da Fonseca Soares +1 more
core +2 more sources
ANTIVIRAL DRUGS IN THE TREATMENT FOR COVID-19
Introduction. Covid-19 is an infectious contagious disease of viral etiology caused by SARS-COv-2. Covid-19 is a highly infectious viral disease caused by SARS-CoV-2. The management of Covid-19 presents significant challenges, and the decision regarding the level of medical care provided, whether in outpatient or hospital settings, relies ...
openaire +1 more source
An Overview of Repurposed Drugs for Potential COVID-19 Treatment
The COVID-19 pandemic caused by SARS-CoV-2 has placed severe constraints on healthcare systems around the globe. The SARS-CoV-2 virus has caused upheaval in the healthcare and economic sectors worldwide. On the 20th of May 2020, the World Health Organisation declared COVID-19 a global pandemic due to the unprecedented number of cases reported around ...
Kamini Govender, Anil Chuturgoon
openaire +3 more sources
Antibiotics in acute bronchitis: a meta-analysis. [PDF]
PurposeMost patients with acute bronchitis who seek medical care are treated with antibiotics, although the effectiveness of this intervention is uncertain.
Bent, S +3 more
core +1 more source
Summary: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen of coronavirus disease 2019 (COVID-19), has infected hundreds of millions of people and caused millions of deaths.
Jianhua Wang +12 more
doaj +1 more source
Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019
Atrial fibrillation is a common clinical manifestation in hospitalized patients with coronavirus disease 2019 (COVID‐19). Medications used to treat atrial fibrillation, such as antiarrhythmic drugs and anticoagulants, may have significant drug ...
Pattara Rattanawong +6 more
doaj +1 more source
Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature [PDF]
In March 2020, the World Health Organization declared the spread of SARS-CoV-2 a global pandemic. To date, coronavirus disease-2019 (COVID-19) has spread to over 200 countries, leading to over 1.6 million cases and over 99,000 deaths. Given that there is
Aly, Besma +9 more
core
Recommendations for the outpatient drug treatment of patients with COVID-19
One of the purposes of outpatient treatment for COVID-19 patients is to prevent severe disease courses and hospitalization. There is a need for evidence-based recommendations to be applied in primary care and specialized outpatient settings.This guideline was developed on the basis of publications that were retrieved by a systematic search for ...
Kaduszkiewicz, Hanna +5 more
openaire +4 more sources
Role of monoclonal antibody drugs in the treatment of COVID-19
Currently clinicians all around the world are experiencing a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical presentation of this pathology includes fever, dry cough, fatigue and acute respiratory distress syndrome that can lead to death infected patients.
Ucciferri C., Vecchiet J., Falasca K.
openaire +3 more sources
Potential therapeutic drug candidates against SARS-CoV-2 (COVID‐19) through molecular docking: A review [PDF]
The severe acute respiratory syndrome coronavirus 2 (known as COVID-19), initially appeared in the Wuhan city of China in December 2019, has become a current medical issue around the world.
Aynaz Nourani +2 more
doaj

